Clear Labs utilizes advanced genomic technologies to enhance food safety and quality. Their platform leverages next-generation sequencing (NGS) to provide comprehensive DNA analysis, enabling the detection of pathogens, allergens, and other contaminants in food products. This technology allows for rapid and accurate testing, significantly reducing the time required for traditional methods and improving the overall reliability of food safety assessments.

In addition to NGS, Clear Labs employs bioinformatics tools to analyze the vast amounts of data generated from their sequencing processes. This integration of data science with genomic analysis enables the identification of specific strains of bacteria and other microorganisms, facilitating a deeper understanding of foodborne pathogens. By combining these technologies, Clear Labs aims to provide actionable insights to food manufacturers and regulators, ultimately contributing to safer food supply chains and enhanced consumer confidence.

United States

Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy - from food-borne pathogens to infectious diseases, including SARS CoV-2. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens.

Clear Labs

Company Details